PsA Single Slide Summaries – May 2022
Apremilast, Ixekizumab, Secukinumab, Sex, Adalimumab, Corevitas Psoriatic Arthritis/Spondyloarthritis Registry, CHOICE, Tofacitinib, JAK Inhibition
Each month the CSF Steering Committee selects the latest published original articles on RA, PsA, and axSpA, focusing on those with data on therapeutic interventions and those that have clinical impact.
Single Slide Summaries – May 2022
Tofacitinib, Baricitinib, JAK Inhibition, Filgotinib, Leflunomide, csDMARDs
Single Slide Summaries – April 2022
Baricitinib, Pain, Oral Surveillance, Upadacitinib, JAK Inhibition, Risk of Infection, Tofacitinib, bDMARDs
Single Slide Summaries - March 2022
Baricitinib, Tofacitinib, Upadacitinib, Adalimumab, Secukinumab, JAK Inhibition, Herpes Zoster
Single Slide Summaries - February 2022
Tofacitinib, ORAL Sequel, JAK Inhibition, IL-6 Inhibition, Baricitinib, Upadacitinib, Adverse Events, Herpes Zoster
Single Slide Summaries – January 2022
Tofacitinib, Upadacitinib, Pain, Filgotinib, Methotrexate, nbDMARDs, JAK Inhibition, SELECT-COMPARE, STAT Pathway